ENTITY
Celltrion

Celltrion (068270 KP)

25
Analysis
Health Care • South Korea
Celltrion, Inc. produces and sells biosimilar products, as well as consignment processing services for other businesses.
more
bullish•Celltrion Inc
•03 Apr 2020 13:52

More Celltrion Block Deals from Temasek Soon? It Seems So

Should we expect more block deals from Temasek? It seems that we should. It seems more evident now that Temasek isn't planning to stay at Celltrion...

Logo
527 Views
Share
bearish•MSCI ACWI Index
•03 Apr 2020 10:05

Global Equities (ACWI-US) Likely to Retest the March Low

We continue to believe global equities (ACWI-US) are likely to test the recent low made on March 23, with an undercut of roughly 10% also in the...

Logo
510 Views
Share
bearish•Celltrion Inc
•02 Apr 2020 03:56

Celltrion Block Deals: Weirdest One to Date

Let's first recap on how the bankers structured these block deals. The discount is quite generous: 8~9.8% for Celltrion and 7~8.8% for Healthcare....

Logo
477 Views
Share
bullish•Celltrion Inc
•01 Apr 2020 20:13

Block Deal Sales of Celltrion & Celltrion Healthcare Stakes by ION Investments

It was reported after the market close today that GIC's investment affiliate ION Investments has put up its shares in Celltrion Inc (068270 KS) and...

Logo
514 Views
Share
bearish•Celltrion Inc
•01 Apr 2020 17:32

Celltrion+Celltrion Healthcare Placement- Discount Looks Enticing but the Deal Appears Opportunistic

Temasek plans to raise US$380m via selling 1.9% stake in Celltrion Healthcare (091990 KS) and another US$132m via selling a 1.5% stake in Celltrion...

Logo
487 Views
Share
x